Trial | Commercial Genetic observational study: Rostock International Parkinson's Disease Study (ROPAD)
The Rostock International Parkinson's Disease Study (ROPAD) is a global observational study focusing on the role of genetics in Parkinson's disease (PD). The major goal of the study is to characterize the genetics of PD to establish a better understanding of the disease progression, diagnosis, and treatment. Throughout this study, 10,000 participants from around the world, made up of PD patients and individuals at high risk of developing PD, will be tested over a period of two years – with the overall aim of identifying 1,500 LRRK2-positive participants.
Recruitment is ongoing and the lab is actively looking for people to participate. It is for anybody with Parkinson’s disease.